Michael Scolaro

Michael Scolaro

Aug 27, 2017

Group 6 Copy 59
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Developing a novel oxysterol antibiotic to combat drug-resistant tuberculosis

    Drug-resistant tuberculosis (TB) is a consistently growing threat to global health. We have developed Oxy291...

    Saving lives with synthetic antivenoms: looking for novel solutions to Lonomia envenoming in Colombia

    Venomous caterpillars of the genus Lonomia cause deadly accidents in Colombia. In Brazil it is estimated...

    Tote-Size portable incubator for rapid field work

    Waiting for lab results is slowing science down! We are designing a fully open source portable incubator...

    Backer Badge Funded